• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

潜在益生元、创新评估方法及其健康应用:综述

Prospecting prebiotics, innovative evaluation methods, and their health applications: a review.

作者信息

Khangwal Ishu, Shukla Pratyoosh

机构信息

Enzyme Technology and Protein Bioinformatics Laboratory, Department of Microbiology, Maharshi Dayanand University, Rohtak, Haryana 124001 India.

出版信息

3 Biotech. 2019 May;9(5):187. doi: 10.1007/s13205-019-1716-6. Epub 2019 Apr 25.

DOI:10.1007/s13205-019-1716-6
PMID:31065487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6485268/
Abstract

Prebiotics are necessary natural and synthetic food ingredients that help in the growth and development of gut microflora. There is a complex relationship between gut dysbiosis and microbes, so alteration in both probiotics and prebiotics can reduce illness of gut, which further plays a decisive role in human health. The prebiotic efficiency can be validated using various in vitro and in vivo experiments, and this gives an important insight to this field. This review focuses on these aspects including the standardized assessment of prebiotics and its metabolic products for customary applications. This review has also summarized the mechanism of their beneficial actions such as immunomodulation, nutrient absorption, pathogen inhibition, etc., and its significance in human nutrition. In addition to this, some fascinating applications of prebiotics in health-related disorders have also discussed, with current challenges in this facet.

摘要

益生元是有助于肠道微生物群生长和发育的必需天然和合成食品成分。肠道生态失调与微生物之间存在复杂的关系,因此益生菌和益生元的改变都可以减少肠道疾病,这对人类健康起着决定性作用。益生元的功效可以通过各种体外和体内实验来验证,这为该领域提供了重要的见解。本综述聚焦于这些方面,包括益生元及其代谢产物在常规应用中的标准化评估。本综述还总结了它们的有益作用机制,如免疫调节、营养吸收、病原体抑制等,以及它们在人类营养中的意义。除此之外,还讨论了益生元在健康相关疾病中的一些有趣应用以及这方面当前面临的挑战。

相似文献

1
Prospecting prebiotics, innovative evaluation methods, and their health applications: a review.潜在益生元、创新评估方法及其健康应用:综述
3 Biotech. 2019 May;9(5):187. doi: 10.1007/s13205-019-1716-6. Epub 2019 Apr 25.
2
Potential Impacts of Prebiotics and Probiotics on Cancer Prevention.益生元和益生菌对癌症预防的潜在影响。
Anticancer Agents Med Chem. 2022;22(4):605-628. doi: 10.2174/1871520621999201210220442.
3
Effectiveness of probiotics, prebiotics, and prebiotic-like components in common functional foods.常见功能性食品中益生菌、益生元和类似益生元成分的功效。
Compr Rev Food Sci Food Saf. 2020 Jul;19(4):1908-1933. doi: 10.1111/1541-4337.12565. Epub 2020 May 26.
4
Impact of Prebiotics on Enteric Diseases and Oxidative Stress.益生菌对肠病和氧化应激的影响。
Curr Pharm Des. 2020;26(22):2630-2641. doi: 10.2174/1381612826666200211121916.
5
Prebiotic effects: metabolic and health benefits.益生元作用:代谢与健康益处。
Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363.
6
Prebiotics and gut microbiota in chickens.鸡体内的益生元与肠道微生物群
FEMS Microbiol Lett. 2015 Aug;362(15):fnv122. doi: 10.1093/femsle/fnv122. Epub 2015 Jul 24.
7
The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.益生菌、益生元和合生菌对肥胖宿主的生化、临床和免疫标志物以及肠道微生物群的影响。
Crit Rev Food Sci Nutr. 2021;61(2):337-355. doi: 10.1080/10408398.2020.1733483. Epub 2020 Mar 10.
8
Beneficial Microbes: The pharmacy in the gut.有益微生物:肠道中的药房。
Bioengineered. 2016;7(1):11-20. doi: 10.1080/21655979.2015.1126015.
9
Prebiotics: tools to manipulate the gut microbiome and metabolome.益生元:操纵肠道微生物组和代谢组的工具。
J Ind Microbiol Biotechnol. 2019 Oct;46(9-10):1445-1459. doi: 10.1007/s10295-019-02203-4. Epub 2019 Jun 14.
10
Prebiotic Oligosaccharides: Special Focus on Fructooligosaccharides, Its Biosynthesis and Bioactivity.益生元低聚糖:特别关注低聚果糖、其生物合成及生物活性
Appl Biochem Biotechnol. 2017 Oct;183(2):613-635. doi: 10.1007/s12010-017-2605-2. Epub 2017 Sep 25.

引用本文的文献

1
The key to intestinal health: a review and perspective on food additives.肠道健康的关键:食品添加剂综述与展望
Front Nutr. 2024 Sep 18;11:1420358. doi: 10.3389/fnut.2024.1420358. eCollection 2024.
2
Antioxidant and Antibacterial Activities of Nano-probiotics Versus Free Probiotics Against Gastrointestinal Pathogenic Bacteria.纳米益生菌与游离益生菌对胃肠道病原菌的抗氧化和抗菌活性
Indian J Microbiol. 2024 Mar;64(1):141-152. doi: 10.1007/s12088-023-01140-2. Epub 2023 Nov 26.
3
Prebiotic, Antipathogenic Bacteria and Hypocholesterolemia Properties of Fermented Rice Bran Extracts Derived from Black Rice and Germinated Brown Rice.黑米和发芽糙米发酵米糠提取物的益生元、抗病原菌及降胆固醇特性
Foods. 2022 Nov 18;11(22):3704. doi: 10.3390/foods11223704.
4
Dysbiosis of Gut Microbiota from the Perspective of the Gut-Brain Axis: Role in the Provocation of Neurological Disorders.从肠-脑轴角度看肠道微生物群失调:在引发神经疾病中的作用
Metabolites. 2022 Nov 3;12(11):1064. doi: 10.3390/metabo12111064.
5
An Updated Review on Prebiotics: Insights on Potentials of Food Seeds Waste as Source of Potential Prebiotics.一篇关于益生元的最新综述:关注食物种子废料作为潜在益生元来源的潜力。
Molecules. 2022 Sep 13;27(18):5947. doi: 10.3390/molecules27185947.
6
Evaluation of Prebiotics through an In Vitro Gastrointestinal Digestion and Fecal Fermentation Experiment: Further Idea on the Implementation of Machine Learning Technique.通过体外胃肠消化和粪便发酵实验评估益生元:关于机器学习技术实施的进一步思考
Foods. 2022 Aug 17;11(16):2490. doi: 10.3390/foods11162490.
7
Plant Prebiotics and Their Role in the Amelioration of Diseases.植物性益生元及其在疾病改善中的作用。
Biomolecules. 2021 Mar 16;11(3):440. doi: 10.3390/biom11030440.
8
In Vitro Prebiotic Effects of Malto-Oligosaccharides Containing Water-Soluble Dietary Fiber.含水溶性膳食纤维的麦芽低聚糖的体外益生元作用。
Molecules. 2020 Nov 9;25(21):5201. doi: 10.3390/molecules25215201.
9
Promising discovery of beneficial in the human gut.在人类肠道中发现有益物质的前景广阔。
3 Biotech. 2020 Jul;10(7):296. doi: 10.1007/s13205-020-02289-z. Epub 2020 Jun 9.
10
An Updated Overview on Nanonutraceuticals: Focus on Nanoprebiotics and Nanoprobiotics.纳米营养保健品最新概述:重点关注纳米益生元和纳米益生菌。
Int J Mol Sci. 2020 Mar 26;21(7):2285. doi: 10.3390/ijms21072285.

本文引用的文献

1
Potential prebiotics and their transmission mechanisms: Recent approaches.潜在的益生元和它们的传递机制:最新方法。
J Food Drug Anal. 2019 Jul;27(3):649-656. doi: 10.1016/j.jfda.2019.02.003. Epub 2019 Mar 4.
2
Inclusion of prebiotics on the viability of a commercial subsp. culture in a tropical fruit beverage.在热带水果饮料中添加益生元对一种商业亚种培养物活力的影响。
J Food Sci Technol. 2019 Feb;56(2):987-994. doi: 10.1007/s13197-018-03565-w. Epub 2019 Feb 4.
3
Single prolonged stress PTSD model triggers progressive severity of anxiety, altered gene expression in locus coeruleus and hypothalamus and effected sensitivity to NPY.单一延长应激 PTSD 模型引发焦虑的严重程度逐渐增加,蓝斑和下丘脑的基因表达改变,以及对 NPY 的敏感性变化。
Eur Neuropsychopharmacol. 2019 Apr;29(4):482-492. doi: 10.1016/j.euroneuro.2019.02.010. Epub 2019 Mar 14.
4
Supplementation of dietary non-digestible oligosaccharides from birth onwards improve social and reduce anxiety-like behaviour in male BALB/c mice.从出生起补充饮食中不可消化的低聚糖可改善雄性 BALB/c 小鼠的社交行为并减少其焦虑样行为。
Nutr Neurosci. 2020 Nov;23(11):896-910. doi: 10.1080/1028415X.2019.1576362. Epub 2019 Mar 14.
5
Combinatory biotechnological intervention for gut microbiota.组合式生物技术干预肠道微生物群。
Appl Microbiol Biotechnol. 2019 May;103(9):3615-3625. doi: 10.1007/s00253-019-09727-w. Epub 2019 Mar 8.
6
Probiotics and Prebiotics in Pediatrics: What Is New?儿科中的益生菌和益生元:有哪些新进展?
Nutrients. 2019 Feb 19;11(2):431. doi: 10.3390/nu11020431.
7
Probiotics, prebiotics and amelioration of diseases.益生菌、益生元和疾病改善。
J Biomed Sci. 2019 Jan 4;26(1):3. doi: 10.1186/s12929-018-0493-6.
8
Role of the gut microbiota in nutrition and health.肠道微生物群在营养与健康中的作用。
BMJ. 2018 Jun 13;361:k2179. doi: 10.1136/bmj.k2179.
9
NMR and ESI-MS spectrometry characterization of autohydrolysis xylo-oligosaccharides separated by gel permeation chromatography.采用凝胶渗透色谱法分离的木低聚糖的自动水解产物的 NMR 和 ESI-MS 光谱特性。
Carbohydr Polym. 2018 Sep 1;195:303-310. doi: 10.1016/j.carbpol.2018.04.088. Epub 2018 Apr 24.
10
Probiotics: Evidence of Oral Health Implications.益生菌:对口腔健康影响的证据。
Folia Med (Plovdiv). 2018 Mar 1;60(1):21-29. doi: 10.1515/folmed-2017-0080.